As we head into the holiday season and gather with family and friends, it’s also the time for respiratory diseases to hit ...

Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...

Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

RSV hospitalizations in US adults reached high levels pre-vaccine, especially impacting those 75 and older, underscoring the ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

The holidays are fast approaching along with cooler weather and various respiratory illnesses. Here's when to get your ...

Some Alberta doctors are calling on the provincial government to make an injection designed to protect newborns from severe ...

Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...

A new shot designed to protect infants against severe illness due to RSV has been approved by Health Canada. It’s covered in ...

Maternal RSV vaccination enhances antibody transfer to newborns, with optimal transfer efficiency observed when given at ...

Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...